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Abstract
The translocator protein (TSPO), previously designated as peripheral-type benzodiazepine receptor, is a protein mainly
located in the outer mitochondrial membrane of eukaryotic cells. TSPO is implicated in major physiological functions and
functionally associated with other proteins such as the voltage-dependent anionic channel, also designated as
mitochondrial porin. Surprisingly, a TSPO-related protein was identified in the photosynthetic bacterium Rhodobacter
sphaeroides but it was initially considered as a relict of evolution. In the present study we cloned a tspO gene in
Pseudomonas fluorescens MF37, a non-photosynthetic eubacterium and we used bioinformatics tools to identify TSPO in the
genome of 97 other bacteria. P. fluorescens TSPO was recognized by antibodies against mouse protein and by PK 11195, an
artificial ligand of mitochondrial TSPO. As in eukaryotes, bacterial TSPO appears functionally organized as a dimer and the
apparent Kd for PK 11195 is in the same range than for its eukaryotic counterpart. When P. fluorescens MF37 was treated
with PK 11195 (10
25 M) adhesion to living or artificial surfaces and biofilm formation activity were increased. Conversely, the
apoptotic potential of bacteria on eukaryotic cells was significantly reduced. This effect of PK11195 was abolished in a
mutant of P. fluorescens MF37 deficient for its major outer membrane porin, OprF. The present results demonstrate the
existence of a bacterial TSPO that shares common structural and functional characteristics with its mammalian counterpart.
This protein, apparently involved in adhesion and virulence, reveals the existence of a possible new inter kingdom signalling
system and suggests that the human microbiome should be involuntarily exposed to the evolutionary pressure of
benzodiazepines and related molecules. This discovery also represents a promising opportunity for the development of
alternative antibacterial strategies.
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Introduction
Benzodiazepines are among the most widely prescribed drugs in
the world [1] and are known as sedative-hypnotic agents efficient
against anxiety, sleep disorders and related troubles. The first
identified target of benzodiazepines, designated as central
benzodiazepine receptor, is corresponding to a secondary site of
subtype A c-aminobutyric acid receptors (GABAA receptors)
expressed in neurons. However, a second type of benzodiazepine
receptor was identified in mammals in 1977. This binding site was
named peripheral-type benzodiazepine receptor (PBR) [2]. As the
structure of this receptor is complex and variable there was rapidly
a large confusion, the same word being used to designate the
multimeric assembling or the benzodiazepine binding protein
itself. For that reason, on the basis of its identified functions in
eukaryotes it was proposed to designate this benzodiazepine
binding protein as ‘‘Translocator Protein’’ (TSPO) [2].
For a receptor, the sub-cellular localization of TSPO is original
since it is essentially present in the outer mitochondrial membrane
[3]. As it has also been found in nuclear and cytoplasmic
membranes it was proposed to distinguish mitochondrial TSPO
and nuclear TSPO [2]. In the mitochondrial membrane, TSPO is
functionally associated with a Voltage Dependant Anionic
Channel (VDAC), also designated as mitochondrial porin, and
with an Adenine Nucleotide Translocase (ANT) essentially
associated with inner membrane [4]. TSPO is present in all
mammalian tissues with the exception of neurons, but differently
expressed according to the cellular function [2,5]. TSPO has a
major role in steroidogenesis and is also implicated in porphyrin
biosynthesis, cell proliferation and apoptosis [5]. Natural ligands of
TSPO are cholesterol, Diazepam Binding Inhibitor (DBI) or
protoporphyrin IX; principal artificial ligands are isoquinoline
carboxamide, such as PK 11195, and benzodiazepines, such as
Ro5-4864. However, benzodiazepine binding requires the pres-
ence of VDAC, whereas PK 11195 binding does not require the
presence of other proteins [5].
TSPO was mostly studied in mammals but this protein is also
expressed in invertebrates [6] and vegetal [7]. Surprisingly, a
functional homologue of TSPO has been identified in the
photosynthetic bacterium, Rhodobacter sphaeroides [8,9]. In this
prokaryote, TSPO negatively regulates pigment biosynthesis and
photosynthesis in response to light and oxygen modifications [8].
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bacterium, Fremyella diplosiphon [10] and in the non-photosynthetic
bacterium, Sinorhizobium meliloti [11]. R. sphaeroides and S. meliloti are
both members of the alpha subdivision of purple bacteria, the
organisms that likely gave rise to the endosymbiont at the origin of
mitochondria. Therefore, the existence of TSPO in these micro-
organisms was considered to be a relict of evolution.
Here we show that a functional ortholog of tspO, i.e. a gene that
has evolved from a common ancestor, is expressed in Pseudomonas
fluorescens, a ubiquitous micro-organism of the gamma-proteobac-
teria subdivision of eubacteria. The distribution of homologous
genes in different bacterial species or strains covering most
taxonomic groups was established. In addition to structural
homology to mitochondrial TSPO, P. fluorescens TSPO has
common pharmacological properties, as demonstrated by its high
affinity for PK 11195. The use of PK 11195 revealed that this
bacterial TSPO is involved in the regulation of adhesion and
virulence and, as a mitochondrial TSPO should be, functionally
associated with a membrane porin. These results suggest that
natural ligands of TSPO, that remain to be identified, should be
involved in inter-kingdom communication. Moreover, it appears
that the behavior of bacteria in the human microbiome can be
modulated by current pharmaceutical agents like benzodiazepines.
On another side, these results suggest a new strategy for the
development of bacterial inhibitors of virulence usable in
complement or in place of antibiotics.
Results
A tspO gene is present in the c-proteobacterium
Pseudomonas fluorescens
In order to investigate the presence of a tspO gene in non-
photosynthetic and typical eubacterium, the published genome of
the environmental and widespread micro-organism Pseudomonas
fluorescens (strain SBW25) was screened by BlastP against the TSPO
sequence of R. sphaeroides 2.4.1. A sequence encoding a protein
with 50% identity to 2.4.1 TSPO of R. sphaeroides was detected in
silico in the genomic sequence of P. fluorescens SBW25. In order to
verify experimentally the presence of this gene in P. fluorescens,
primers were designed from the P. fluorescens SBW25 tspO gene
sequence and used in our reference strain, P. fluorescens MF37. A
PCR-amplified fragment of 438 bp, encoding 146 amino acids
was produced from P. fluorescens MF37 (NCBI accession number
FJ185105). The fragment was cloned into the pMOSBlue plasmid
and sequenced. A BlastP search of the full fragment sequence
confirmed that it was a TSPO-like protein. Calculation of the
topological structure of this protein by TopPred revealed a five
transmembrane helix structure analogous to that of R. sphaeroides
2.4.1 [12] and mitochondrial TSPO [13], though the extracellular
N-terminus is absent and the C-terminus shortened (Fig. 1). The
first cytoplasmic loop is highly conserved (80% similarity including
46.7% identity) between R. sphaeroides 2.4.1 and P. fluorescens MF37.
Moreover, Lys21 and Lys31 (corresponding to residues 26 and 36
in R. sphaeroides 2.4.1.) are fully conserved in both amino acid
identity and the distance between the two residues. The software
PSORTb indicated with high probability association of TSPO
with the inner bacterial membrane and it was interesting to note
that it was not possible to extract TSPO from the sub-fraction
corresponding to the outer membrane of the bacterium. In
agreement with its probable membrane localization, a peptidogly-
cane-binding domain signature was detected between residues 66
and 81 in the third transmembrane helix. Using specific primers
designed from the P. fluorescens MF37 tspO gene sequence, we
successfully amplified homologous sequences in other strains of P.
fluorescens, including the biovar V strain, MF0, as well as the clinical
biovar I and II strains, MFY70, MFY162, and MFN1032 (Fig. 2).
Intriguingly, a tspO fragment could be amplified from the
MFN3597 strain, previously identified as P. putida [14], but not
from the clinical strain, P. fluorescens MFY63 (biovar II).
Sequencing and alignment of the translated TSPO sequences
from the amplified fragments revealed 90% similarity. An
unexpected result was the impossibility to amplify a tspO gene in
Pseudomonas aeruginosa PAO1 (data not shown).
TspO orthologs are widely, but heterogeneously
distributed in eubacteria
Since our results suggested a broader distribution of TSPO than
expected, the TSPO sequence from P. fluorescens MF37 was used to
search for homologous proteins in sequenced bacterial genomes
available in the NCBI databank. We found that 97 different
eubacterial species or strains encompassing most of the different
taxonomic groups contained a TSPO-related protein that we
propose to designate as bacterial TSPO. Bacterial TSPO appears
to be widely distributed in eubacteria, including human pathogens
such as Bacillus anthracis, Legionella pneumophila, Staphylococcus
haemolyticus, and Clostridium perfringens. A cladogram was constructed
based on the 97 bacterial TSPO sequences (Fig. 3). Although the
sequence of human mitochondrial TSPO was included in the
series, the tree remained unrooted. In addition, it was not possible
to distinguish any specific clusters grouping homogenous bacteria,
with the single exception of a cluster of fluorescent Pseudomonas that
included P. fluorescens MF37 and SBW25, as well as the P. syringae
pathovars phaseolicola, syringae, and tomato. In fact, this cluster was
certainly an artifact due to the presence of several identified
sequences from closely related bacteria. Even the P. fluorescens Pf0-
1 strain remained separate from the cluster of other fluorescent
Pseudomonas. The absence of tspO in P. aeruginosa was confirmed by
BlastP search in the strain PAO1 and in all genomic sequences
available on the site Pseudomonas.com, i.e. strains PA7, PA14 and
LESB58. In contrast, homologous sequences were found in
different archaeal prokaryotes (data not shown). The genomic
environment of tspO in fluorescent Pseudomonas was analyzed. The
sequences flanking tspO in P. fluorescens MF37 were sequenced and
those in P. fluorescens Pf0-1, SBW25, P. syringae pv. phaseolicola
1448A, pv. syringae B728a, and pv. tomato DC3000 were retrieved
from the NCBI databank. The sense, size, and putative functions
of the genes in the flanking regions of tspO were different in the six
bacterial types but we observed that the tspO environment was
particularly rich in transposase genes (Fig. 4). In P. syringae pv.
phaseolicola, a gene encoding a transposase lies immediately
upstream of tspO (position 1) with four additional transposase
genes lying upstream (position 14) or downstream (positions 15, 16
and 17) of tspO. Sequences encoding transposases were also
observed near tspO in another two strains of P. syringae (DC3000
strain: upstream gene positions 16 and 17 and downstream
positions 23, 24, 25, 26, and 29; B728a strain: upstream position
31 and downstream position 17 and 31) and in P. fluorescens Pf0-1
(upstream position 17). The GC content of the upstream and
downstream sequences was determined in the different Pseudomonas
whose genomic environment was studied. Differences between the
GC contents of the tspO gene in a same bacterial species were
generally lower than 3% (maximum 5%) whereas inter-species
variations reached 9%.
TspO is differently expressed in fluorescent Pseudomonas
As the presence of a gene is not a warranty of its functionality,
expression of the tspO gene was studied in P. fluorescens MF37 and
related strains by RT-PCR and western blot analysis of total
TSPO in Bacteria
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RT-PCR revealed the expression of mRNA coding TSPO in
extracts from P. fluorescens MF37 grown in normal or in reduced
oxygen conditions without visible difference (data not shown).
Western blot analysis of P. fluorescens MF37 extracts allowed to
detect a TSPO immunoreactive band corresponding to a 37 kDa
Figure 1. Comparison of the putative topological organization of bacterial and mitochondrial TSPO. (a) Pseudomonas fluorescens MF37
bactTSPO. (b) BactTSPO from Rhodobacter sphaeroides 2.4.1 recalculated from Yeliseev and Kaplan [12]. (c) Mitochondrial TSPO [13]. P. fluorescens
MF37 bactTSPO has a typical five transmembrane helix structure, a larger L1 intra-cytoplasmic loop, and an extended cytoplasmic C-terminal end. In
contrast, the extracellular N-terminal end is absent, and a peptidoglycane binding domain signature is present between the L2 loop and H3
transmembrane domain.
doi:10.1371/journal.pone.0006096.g001
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expected for bacterial TSPO (17 kDa) but ESI-MS/MS analysis
(Fig. 5b) indicated a 92% recovery between experimental and
theoretical masses and confirmed that this immunoreactive band
was actually bacterial TSPO. A same protein was detected in
extracts of P. fluorescens MF0, the strain from which MF37 was
produced [15]. In contrast, although PCR allowed us to amplify
TSPO homologous sequences in P. fluorescens MFY70, MFY162,
MFN1032, and in P. putida MFN3597, western blot analysis did
not detect the expression of bacterial TSPO-like immunoreactive
proteins in these micro-organisms.
Bacterial TSPO expressed in Pseudomonas fluorescens
MF37 shares pharmacological properties with eukaryotic
mitochondrial TSPO
The pharmacological properties of P. fluorescens MF37 bacterial
TSPO were investigated using a specific ligand of eukaryotic
mitochondrial TSPO, PK 11195 [16]. A total protein extract of
MF37 was separated by SDS-page electrophoresis, transferred
onto nitrocellulose membrane, and hybridized with tritiated
PK11195 ([
3H]-PK 11195). The main binding peak of [
3H]-PK
11195 was detected at the position of the 37 kDa band identified
by western blot as containing MF37 bacterial TSPO (Fig. 6a).
Secondary binding peaks were observed on proteins of higher
molecular mass that were not recognized by the TSPO antiserum.
A Scatchard study was then performed using the same tracer and
membranes purified from P. fluorescens MF37. The Kd determined
under these conditions (0.92 nM) in the same range as what has
been previously established for PK 11195 binding to mammalian
mitochondrial TSPO (1.5 nM) [17] (Fig. 6b). These results
suggest that P. fluorescens MF37 bacterial TSPO recognizes PK
11195 as a ligand, and we decided to use this molecule to
investigate the functional role of MF37 TSPO.
Bacterial TSPO regulates the adhesion and cytotoxic
activity of Pseudomonas fluorescens
Owing to the role of TSPO in the adaptation of R. sphaeroides to
changes in oxygen concentrations [9], we first investigated the
effect of PK 11195 on the growth kinetics of P. fluorescens MF37
cultured under normal aerobic or low oxygen conditions.
Exposure of the bacteria to PK 11195 (10
25 M) at any time of
the growth phase (i.e., at the onset of growth, mid-exponential
growth phase, or at the beginning of stationary phase) did not alter
the growth kinetics. Since, in Pseudomonas, mobility is indirectly
controlled by oxygen concentration [18], we investigated the effect
of PK11195 on bacterial mobility and adherence potential.
Treatment with PK 11195 did not alter the swimming or
swarming mobilities of P. fluorescens MF37. In contrast, the
adhesion potential of bacteria on glass and on eukaryotic (glial)
cells was markedly increased (+168669% and +7069%, respec-
tively) by PK 11195 exposure (Fig. 7). The ability of P. fluorescens
MF37 to form biofilms on polystyrene was also significantly
increased, albeit to a limited degree (+1664%). However, these
changes in the adhesion potential of P. fluorescens were not
associated with global variations in surface polarity, as demon-
strated by measuring the bacterial affinity to solvent. P. fluorescens
MF37 is non-invasive on glial cells and PK 11195 does not modify
this behavior (data not shown). Given that bacterial adhesion and
virulence are linked, we investigated the effect of PK 11195 on the
cytotoxicity of P. fluorescens MF37 using the release of nitrites and
lactate dehydrogenase (LDH) as markers of apoptosis and necrosis,
respectively [19]. In these experiments, bacteria were grown with
PK 11195 (10
25 M, 24 h) and carefully rinsed to remove any trace
of ligand before transferring them to the growth medium of
eukaryotic (glial) cells. Under these conditions, the apoptotic-like
effect of P. fluorescens MF37 was strongly decreased (249618%)
(Fig. 8). Similar results were observed at doses of PK 11195
ranging from 10
26 to 10
28 M. The same experiment was repeated
using P. fluorescens 373, a mutant of MF37 lacking the gene for
OprF (the major porin of the bacterium) and P. fluorescens 373O,
the oprF-complemented mutant. The apoptotic-like effect of the
mutant 373 was identical to that of MF37 but its necrotic-like
activity was significantly reduced. PK 11195 had no effect on the
cytotoxicity of this oprF deleted mutant of P. fluorescens. OprF-
transcomplementation allowed partial reversion of the phenotype
with almost total restoration of the original necrotic-like activity of
bacterium. However to the apoptotic-like activity was reduced in
the OprF-complemented mutant 373O and it was not possible to
visualize restoration of the sensitivity to PK 11195.
Discussion
The results of the present study demonstrate the existence of a
tspO gene in a wide variety of bacterial species and its expression as
bacterial TSPO protein in the micro-organism Pseudomonas
fluorescens, where its role in virulence regulation appears to be
entirely different than initially proposed for Rhodobacter sphaeroides
and a-proteobacteria. As observed in the case of other proteins
[20,21] whose structures were strongly preserved during evolution,
functions can evolve independently and the present results reveal
that it is necessary to reconsider the way we interpret the presence
of TSPO in bacteria.
Pseudomonas, and particularly Pseudomonas fluorescens, are ubiqui-
tous and non-photosynthetic micro-organisms that diverged long
time ago from the ancestor of Rhodobacter sphaeroides. Because of the
high versatility of this micro-organism [22] we conducted most of
our bioinformatic studies on the basis of the bacterial TSPO
sequence from the reference strain, P. fluorescens MF37. P. fluorescens
MF37 is a typical psychrotrophic bacterium member of the biovar
V subdivision of the species and its physiological characteristics
have been extensively investigated in our laboratory. In addition to
cloning of the tspO gene of P. fluorescens MF37, we attempted to
produce a deletion mutant by different techniques ranging from
simple crossing over and cloning in pMOS, pME3087 or
pKNOCK suicide vectors to double crossing over using the Cre-
lox system but we never succeeded. In eukaryotes deletion of the
tspO gene is lethal [23] suggesting involvement of TSPO in
essential physiological functions and our observations indicate that
it should be also the same in P. fluorescens. We propose to designate
Figure 2. Identification of tspO genes in fluorescent Pseudomo-
nas. PCR amplification of tspO-encoding sequences in the biovar V
strains Pseudomonas fluorescens MF37 and MF0, the clinical biovar II
strain Pseudomonas fluorescens MFY70, the biovar B strain Pseudomonas
putida MFN3597, and the biovar I strains, Pseudomonas fluorescens
MFY162 and MFN1032. The biovar II strain, Pseudomonas fluorescens
MFY63, lacks tspO-related sequences. Std: Molecular mass standards.
doi:10.1371/journal.pone.0006096.g002
TSPO in Bacteria
PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e6096Figure 3. Amino acid sequence cladogram showing the relationships between bacterial TSPO. Bacterial names, accession numbers, and
taxonomic groups are indicated for each branch. Bold characters indicate c-proteobacteria, and the black arrow indicates the position of TSPO expressed
in human mitochondria. The two dotted boxes indicate fluorescent Pseudomonas strains containing a bactTSPO gene (P. fluorescens and P. syringae). The
degree of statistical support for branches was determined with 1000 bootstrap replicates. All branches showed less than 30% divergence.
doi:10.1371/journal.pone.0006096.g003
TSPO in Bacteria
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‘‘mitochondrial TSPO’’ and ‘‘nuclear TSPO’’ in eukaryotes [2].
The topological structure deduced from the TSPO sequence of
P. fluorescens MF37, characterized by a five transmembrane helix, is
analogous to that of R. sphaeroides 2.4.1 and mitochondrial TSPO
[12,13], though it appears to be partially or completely truncated
at the N- and C-terminus. The structure of the TSPO molecule is
particularly well preserved in the regions essential for its function,
such as the first cytoplasmic loop, considered to be the main
ligand-binding domain of the protein [12]. However, there is a
divergence of orientation between bacterial and mitochondrial
TSPO. In mitochondria, the N-terminus of TSPO is oriented in
direction of the matrix [13]. In contrast, in R. sphaeroides bacterial
TSPO appears inserted in the opposite sense, i.e. with the N-
terminus exposed to the extracellular side [12]. A same orientation
was predicted by TopPred for TSPO in P. fluorescens. The origin of
this inversion of orientation should be ascribed to the fact that in
eukaryotes TSPO is encoded in the nuclear genome and
translocated to the outer membrane of the mitochondrium [24]
whereas in bacteria, which synthesise TSPO in their cytoplasm,
the protein has to be inserted from the inside of the prokaryotic
cell. The localization of TSPO in the membranes of P. fluorescens is
apparently different from that previously found. In R. sphaeroides
[12], as in mitochondria [2], TSPO is shown associated to the
outer membrane. In contrast, calculations using the software
PSORTb and extraction tests on bacterial sub-membrane
fractions both suggest association of TSPO to the inner membrane
of P. fluorescens. In support of this hypothesis it is known that in
Gram-negative bacteria, proteins folded in a-helixes are essential-
ly, if not exclusively, associated to the inner membrane [25]. The
presence of a peptidoglycan binding domain in the C terminal
region of P. fluorescens TSPO is consistent with association of this
protein to the bacterial membranes. A similar peptidoglycan
binding signature was also observed in the porin OprF of
Pseudomonas aeruginosa [26] and OmpA of Erwinia carotovora [27]
but the role of this hidden domain in TSPO is unexplained.
Experimental studies could reveal differences with predictive
model, as described for mammalian TSPO by Murail et al. [28]
making possible that the peptidoglycan domain of TSPO was
more exposed to the surface and have same function of anchoring
to periplasmic peptidoglycan as described for the C terminal
region of P. aeruginosa OprF [26].
Since we have collected strains of P. fluorescens from diverse
environments, including from clinical origins, where they were
identified as opportunistic pathogens [14], we searched for the
presence of a tspO gene in various biovar and temperature
variants of the species. Primers derived from the MF37 tspO gene
sequence revealed that homologous sequences are indeed present,
Figure 4. Comparison of tspO genomic environments among Pseudomonas. Physical maps of the regions upstream and downstream of tspO
are shown for P. fluorescens strains MF37, SBW25, and Pf0-1 as well as P. syringae strains 1448A (pathovar phaseolicola), DC3000 (pv. tomato), and
B728a (pv. syringae). ORF: non-identified putative protein, ¤ Data obtained from Blast, * Protein putative function. Black areas represent intergenic
regions.
doi:10.1371/journal.pone.0006096.g004
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also in a closely related species, Pseudomonas putida. The high
degree of similarity of the translated sequences (90%) suggests that
the structure of TSPO is conserved between these bacteria.
Therefore, we were particularly surprised by our failure to detect a
tspO-like sequence in one clinical strain of P. fluorescens and in
Pseudomonas aeruginosa PAO1. As confirmed later in an in-silico
study on all eubacterial sequences available in the NCBI databank,
the distribution of the tspO gene is wide but very irregular. In
addition, although we could build a cladogram over 97 bacterial
TSPO sequences, it was impossible to define specific clusters
corresponding to sub-types of this protein. The irregular presence
of TSPO in eubacteria can not be simply explained by a lack of
homogeneity of the species whose genomes were registered in the
NCBI data-bank or by an insufficient volume of data. In contrast,
as suggested by the detailed study of the genomic environment of
tspO in fluorescent Pseudomonas, this situation probably reflects
an original mechanism of acquisition of TSPO. Indeed, in the
different genomes of Pseudomonas where TSPO was detected, we
noted at the vicinity of the tspO gene the presence of genes
encoding transposases. This topographical organization should
favor gene exchange and, consequently, the irregular distribution
of the protein. Although, there is no precise limit values for
differences between CG contents in individual genes, the low level
of variations of the GC contents between tspO and the
neighboring genes in each individual species or strains [29]
suggests that tspO does not results from a recent gene transfer. In
Figure 5. Expression of TSPO in fluorescent Pseudomonas. (a)
Western blot analysis of total proteins extracts from the biovars V
Pseudomonas fluorescens MF37 and MF0, the clinical strains of
Pseudomonas fluorescens MFY70, MFY162, and MFN1032, and Pseudo-
monas putida MFN3597. (b) Alignment of the fragments obtained by
ESI-MS/MS analysis of the TSPO immunoreactive bands extracted from
MF37 and showing 92% recovery with the theoretical sequence of the
protein. Std: Molecular mass standards.
doi:10.1371/journal.pone.0006096.g005
Figure 6. Binding of PK 11195 to bacterial TSPO of Pseudomo-
nas fluorescens MF37. (a) Demonstration of the binding of [
3H] PK
11195 at the position of the TSPO-immunoreactive band visualized by
western blots in P. fluorescens MF37 extracts. (b) Scatchard plot
showing the binding characteristics of PK 11195 to TSPO of P.
fluorescens MF37. The maximal binding potential (Bmax) is 0.087
pmole.m g
21 bacterial protein and the Kd is 0.92 nM.
doi:10.1371/journal.pone.0006096.g006
Figure 7. Effect of PK 11195 on Pseudomonas fluorescens MF37
adhesion to glass or eukaryotic cells, and on biofilm formation
on PVC. Results are expressed as percentages of the values measured
in the absence of treatment (100%). These changes were not associated
with variations in the global surface polarity of bacteria. ***P,0.001.
doi:10.1371/journal.pone.0006096.g007
TSPO in Bacteria
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expression is precisely regulated. Whereas a tspO gene was
detected in 5 of the 6 strains of P. fluorescens studied and alignment
of the translated sequences suggested a high degree of homology of
the protein, the TSPO protein was only detected in MF37 and in
its parental strain, MF0. The identity of the protein was confirmed
by ESI-MS/MS analysis, although the apparent mass of the
protein was double what was predicted, suggesting that, as shown
by Yeliseev & Kaplan [12] and Delavoie et al. [30], bacterial
TSPO exists as a dimer. Secondary binding peaks for the specific
ligand of TSPO PK 11195 were observed but they should not
represent trimers or tetramers of TSPO since they were not
recognized in western blot by the antiserum. The disparities
between the results of PCR and western blot analysis could result
either from conformational variations making TSPO undetectable
by the antiserum (an unlikely situation because the polyclonal
antiserum shows cross reactivity with different forms of TSPO,
including those of vegetal origin [7]), or from the existence of
specific regulatory mechanisms in the different strains which could
repress TSPO expression in our experimental conditions.
Altogether, these results suggest that bacterial TSPO is a protein
whose acquisition and expression is precisely regulated, as is
normally observed for molecules with important physiological
functions.
In the bacterial TSPO of MF37, the high degree of conservation
in the region considered to be the ligand-binding domain of the
protein is consistent with our observation that PK 11195, a high-
affinity ligand of mitochondrial TSPO, was also recognized by this
protein with nanomolar affinity. This observation provided an
opportunity to directly probe the function of bacterial TSPO in P.
fluorescens. PK 11195 did not modulate bacterial growth and
mobility, and this result was independent of the oxygenation
conditions of the bacterium. This is different from what has been
observed in R. sphaeroides, where TSPO is considered to be an
oxygen sensor [9], and is not surprising considering P. fluorescens is
not a photosynthetic bacterium and that the metabolism,
structural, and even genomic organization of the two micro-
organisms have very few common points. The observation that PK
11195 increases the adhesion of P. fluorescens on diverse surfaces
ranging from glass to eukaryotic cells and also stimulates the
biofilm formation potential of bacteria on polystyrene is essential,
since bacterial adhesion is considered a key point in virulence
expression [31]. Bacterial adhesion is mediated by at least three
types of forces generated by surface polarity, pili and flagella, or
specific membrane proteins. As PK 11195 has the same effect on
bacterial adhesion to polar (glass), complex (eukaryotic cells), and
hydrophobic surfaces (polystyrene) and does not modify the
affinity to solvents of the bacteria, global variations of surface
polarity can be excluded. Considering that the flagellar-dependent
mobility of P. fluorescens was not influenced by PK 11195
treatment, our results suggest that this molecule acts on the
configuration and/or activity of a specific membrane adhesin. In
P. fluorescens, the porin OprF is the major outer membrane protein
and implication of this molecule in adhesion to living cells [32],
matrix protein [33], and abiotic surfaces [34] has already been
demonstrated. As we did not observe any binding of PK 11195 to
OprF by western blot, we can only postulate an indirect action of
the drug on this protein, a hypothesis that was tested in the last
part of the study.
When P. fluorescens MF37 was pre-treated with PK 11195, its
apoptotic-like effect on eukaryotic cells (glial cells) was significantly
reduced. In contrast, the necrotic-like effect of the bacterium was
not changed, suggesting that PK 11195 was not acting on the
release of enzymes and/or soluble toxins, but was modulating a
specific apoptotic signal generated by the bacterium, and probably
associated with outer membrane surface components. The same
experiment was conducted in a P. fluorescens OprF-deficient mutant
derived from MF37 (MF373). The apoptotic-like effect of MF373
was identical to that of its parent strain whereas its necrotic activity
was markedly reduced. This difference should be ascribed to the
absence of OprF which is an adhesin required for contact
mediated cytotoxicity [32,33] and has intrinsic cytotoxic potential
[35,36]. In this oprF-deleted strain, PK 11195 does not modules
Figure 8. Effect of PK 11195 on the cytotoxicity of Pseudomonas
fluorescens MF37 and its OprF-deficient (373) and complemented
OprF-deficient (373O)mutants.(a) Effect of PK11195 (10
25 M)onthe
apoptotic-like activity of the bacteria determined by measuring nitrite
production (NO2
2) resulting from NO biosynthesis by eukaryotic cells. (b)
Effect of PK 11195 (10
25 M) on necrotic-like effect of P. fluorescens MF37,
373 and 373O determined by lactate dehydrogenase (LDH) activity
released by eukaryotic cells. ***P,0.001. NS: not significant.
doi:10.1371/journal.pone.0006096.g008
TSPO in Bacteria
PLoS ONE | www.plosone.org 8 June 2009 | Volume 4 | Issue 6 | e6096the apoptotic-like activity of the bacterium. These results indicate
that PK 11195 acts on a process that regulates the virulence of P.
fluorescens and requires expression of OprF. The necrotic-like
activity of P. fluorescens was almost completely restored in the oprF-
transcomplemented strain P. fluorescens 373O whereas its apoptotic
effect was reduced. In these conditions it was not possible to
observe a restoration of the inhibitory activity of PK 11195 on
apoptosis. This partial phenotypic reversion in the complemented
strain can be explained by the fact that plasmidic oprF-
transcomplementation does not fully reproduces the regulation
exerted over the endogenous chromosome-bound gene and
underlines the phenotypic sensitivity of Pseudomonas to plasmidic
of chromosomal transformations.
From these results, it is tempting to speculate that, as is the case
of mitochondrial TSPO and VDAC in peripheral-type benzodi-
azepine receptors, dimers of bacterial TSPO interact with a porin,
namely OprF, and form hyper-structures in the membrane of P.
fluorescens. The degree of homology of mitochondrial and bacterial
TSPO is consistent with evolution from a common ancestor. In
contrast, although VDAC and OprF are both porins, structural
similarities between the two proteins are very low. Therefore,
functional association between bacterial TSPO and OprF appears
more as the result of evolutionary convergence. We should be then
in this unique hyperstructure in the presence of a double and
opposite evolutionary mechanism.
Although the natural ligand(s) of TSPO remains controversial,
even in mammals, a first consequence of the present work is that it
is highly probable that such molecules should be detected both by
bacteria and eukaryotes and participate to inter-kingdom
signaling. Communication between bacteria and eukaryotes using
common molecules was only recently explored under the general
identification of Microbial Endocrinology [37] but the conse-
quences of such mechanisms are multiple. Indeed, since
benzodiazepines are widely prescribed in medicine, these drugs
are certainly exerting a continuous pressure on the physiology of
the bacterial species of the human intestinal microflora. The
resulting effect of these chronic and unsuspected interactions
between benzodiazepines and the commensal microbiome re-
mains to be investigated. On another side, this study suggests new
hypothesis for the development of antibacterial molecules acting as
virulence inhibitors. Indeed, by reducing the virulence of germs,
PK 11195 or related molecules may allow the host to clear an
infection without generating resistant forms of bacteria. This
strategy is a new path to find alternative solutions to antibiotics as
urgently requested by the World Heath Organization [38].
(Use of PK11195 and derived molecules as inhibitors of virulence is
covered by the French Patent No. 2 894 478 and is the property of
ADIPpharm).
Materials and Methods
Bacterial strains and culture conditions
P. fluorescens MF37 (biovar V) is a spontaneous mutant of the
MF0 strain isolated from raw milk [15]. P. fluorescens clinical
strains, MFY162 and MFN1032, are biovar I [14], whereas
MFY63 and MFY70 are biovar II [39]. Clinical strain, MFN3597
is a P. putida biovar B [14]. For all strains, cultures were grown in
Nutrient Broth (NB; Merck) medium (28uC, 180 rpm). Cultures
were inoculated at an initial OD580 nm of 0.08 and harvested in
early stationary phase.
Cloning and sequencing of bacterial tspO in MF37
The nucleotide sequence of MF37 bacterial tspO gene was
deposited in the Gen-Bank database under accession number
FJ185105. Primers 392-1 (CCGACCATGACCTTCTTCAT)
and 392-19 (GCCAGGTAAGGGAACAGGAT) were designed
from the P. fluorescens SBW25 tspO genomic sequence (Sanger
Institute http://www.sanger.ac.uk). Purified chromosomal DNA
was PCR amplified using 35 cycles of denaturation (30 s, 94uC),
hybridization (1 min, 60uC) and elongation (1 min, 72uC). The
PCR fragment was cloned into the pMOSBlue vector, according
to the supplier’s protocol (pMOSBlue Blunt ended kit, Roche).
Positive colonies were confirmed by PCR using the plasmidic
universal primers, T7 and U19. Recombinant plasmids were
extracted using the QIAprep Spin Miniprep (Qiagen). Plasmids
were sequenced on both strands by Genomexpress (www.genome-
express.com).
In-silico analysis
The localization of TSPO and the predicted transmembrane
structure were determined using the TopPred (http://mobyle.
pasteur.fr/cgi-bin/MobylePortal) and PSORTb v2.0.4 (http://
www.psort.org) programs [40]. The predicted structure of MF37
TSPO was compared to that of R. sphaeroides 2.4.1, recalculated
from Yeliseev & Kaplan [12] and mitochondrial TSPO [13].
Existence of a peptidoglycan-binding signature
(NXXLSXXRAXXVXXXL), based on the sequence of OmpA
[27], was investigated. Homologies between the sequence of MF37
TSPO and those of other eubacteria were determined by
searching the NCBI databank using the BLASTP program.
Sequences were aligned using the multiple protein alignment
algorithm, Clustal W [41], and analyzed using Philip version 3.5
(DNA parsimony program). The degree of statistical support for
branches was determined with 1000 bootstrap replicates. The
cladogram was visualized by Treeview 1.6.6. For analysis of the
tspO genomic environment, flanking sequences in strains P.
fluorescens Pf0-1 and P. syringae pv.syringae (B728a), phaseolicola
(1448A), and tomato (DC3000) were retrieved from the Pseudo-
monas Genome Database (http://www.pseudomonas.com). For
SBW25, 5,000 bp upstream and downstream of tspO were
retrieved from the Sanger Institute (http://www.sanger.ac.uk)
and translated into protein sequence (http://insilico.ehu.es). The
hypothetical gene sequences were blasted against the prokaryotic
NCBI database (http://www.ncbi.nlm.nih.gov) and for each one,
the most likely homologue was included in the map of the genomic
environment.
PCR, Western blot and ESI MS-MS analysis
For PCR analysis, chromosomal bacterial DNA was extracted
and subjected to PCR using primers designed from MF37 tspO to
allow amplification of the last 363 bp ( Tav363F:AAA GGA TCC
GGT ACG AAT CCC TGG TCA AA and Tav363R: AAA AAG
CTT TCT TAT TCC GCA GGA TCG AG). PCR was
performed using 30 cycles of denaturation (30 s, 94uC), hybrid-
ization (45 s, 60uC) and elongation (45 s, 72uC). For Western blot
studies, proteins (40 mg), obtained from MF37 in early stationary
phase, were separated by SDS-PAGE on a 15% acrylamide gel.
Proteins were transferred for 30 min (490 mA) onto nitrocellulose
membranes. Membranes were saturated for 1 h at 20uC in Tris-
buffered saline (TBS: 20 mM Tris pH 7.5; 500 mM NaCl)
containing 2% skim milk and 0.5% bovine serum albumin
(BSA). Membranes were then incubated overnight at 4uC with
rabbit anti-mouse mitochondrial TSPO [42] in blocking solution
(1:2,000). Membranes were rinsed twice with TBS containing
0.1% Tween 20 (TTBS) and incubated for 1.5 h at 20uC with
alkaline phosphatase-conjugated goat anti-rabbit antibody (Biorad)
in TTBS-1% BSA (1:3,000). The colorimetric reactions were
developed according to the instructions of the provider (BioRad).
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MS), total bacterial proteins were extracted, as previously
described [43], and an equivalent of 80 mg protein was separated
by SDS-PAGE. The gel was cut vertically into two parts. One side
was used for western blot analysis, while the other was stained with
coomassie blue. The band containing TSPO-like immunoreactive
protein was processed for ESI MS-MS analysis (UMR INRA1253,
Rennes, France). The resulting peptide sequences were analyzed
using ‘‘Findpeptool’’ software (http://www.expasy.org/tools/
findpept.html) to compare theoretical and experimental masses.
Radioligand binding studies
Tritiated PK 11195 (
3H-PK 11195; 73.6 Ci/mmole) was
obtained from Perkin Elmer. Proteins were transferred onto
nitrocellulose membranes and saturated for 1 h in the blocking
solution already described. Membranes were rinsed twice in TBS
and incubated for 30 min at 20uC in TBS containing 2.5 mCi/mL
3H-PK 11195. Membranes were then rinsed two times for 10 min
in TBS and cut into 3 mm fragments. Each fragment was
transferred to minivials containing 5 mL of scintillation liquid
(Perkin-Elmer). For Scatchard studies, bacterial membranes were
obtained by sonication on ice (four cycles of 30 s followed by
microscopic control), adjusted to a final concentration of 60 mg
membrane proteins/250 ml Tris-HCl buffer (50 mM, pH=7.4),
and incubated with
3H-PK 11195 at concentrations ranging from
0.6 to 59 nM. Mixtures were subjected to three steps of
centrifugation (10 min, 10,5006g,4 uC) to remove membrane-
bound tracer and rinsed with 0.5 mL ice-cold Tris-HCl buffer.
Non-specific binding was determined by repeating the experiment
in the presence of non-radioactive PK 11195 (30 mM).
Biophysical studies
Due to its hydrophobicity, PK 11195 was dissolved in ethanol
before mixing with culture medium. The final ethanol concentra-
tion was kept to 0.01%. All control experiments were performed in
the presence of a same percentage of ethanol (0.01%). In normal
oxygenation conditions, the culture medium corresponded to one-
tenth of the volume of the culture vial volume, and one-half for
reduced oxygenation conditions. Growth kinetics were determined
by measuring OD580 nm. Swimming mobility was evaluated by
puncture inoculation of plates containing NB supplemented with
0.3% agar. Swarming mobility tests were performed using an
identical protocol, except that bacteria were deposited at the
surface of NB supplemented with 0.5% agar. Bacterial adhesion to
glass surfaces was studied using microscopic slides cleaned with
ethanol and TFD4 detergent. Adhesion tests were performed by
immersing slides for 2 h at 28uC in bacterial culture (10
8 CFU/
mL) and staining with acridine orange (0.01%, 20 min). For
biofilm formation studies, bacteria were resuspended in NB at an
OD595 nm of 0.4. A constant volume of 100 mL of suspension was
laid in a 96 well-plate and incubated at 28uC for 24 h in a water-
saturated atmosphere. Each well was then rinsed and incubated in
0.1% crystal violet in water for 30 min. The excess of dye was
removed and the crystal violet-stained biofilm was then dissolved
with sodium dodecyl sulfate (1%), and the OD595 nm of the extract
was measured. Possible variations in the surface polarity of the
bacteria were investigated using the microbial adhesion to solvent
technique described by Bellon-Fontaine et al. [44] and hexadecane
as hydrophobic solvent.
Cell adhesion/invasion assays and cytotoxicity tests
Primary cultures of glial cells were obtained from newborn
Wistar rats according to the recommendations of the French
Ethics Committee (Agreements AGEXP27.01 and 27.06). The
culture medium consisted of DMEM and Ham’s medium (2:1)
supplemented with 10% fetal calf serum, 2 mM glutamine,
0.001% insulin, 5 mM HEPES, 0.3% glucose, and 1% antibiot-
ic-antimycotic solution. Cells were allowed to grow for 12 days to
reach confluence. Just before the infection test, bacteria harvested
by centrifugation (6,000 rpm, 10 min) were resuspended in glial
cell culture medium without antibiotics to a final concentration of
10
6 CFU/mL. Effect of PK 11195-treatment on adhesive and
invasive behaviors of bacteria was evaluated using the gentamicin
survival assay [45]. The effect of PK 11195 on the cytotoxicity of
P. fluorescens MF37 was determined through measurement of nitrite
(NO2
2) and lactate dehydrogenase (LDH) release by glial cells
following a 24 h incubation in culture medium with bacteria. The
use of these indirect methods for the study of apoptosis and
necrosis has been previously validated [19]. Control studies were
performed to verify the absence of nitrite or LDH production by
bacteria. The concentration of nitrites in the incubation medium
was determined using the Griess reaction. The concentration of
LDH in the medium was determined using the Cytotox 96H
enzymatic assay (Promega, France). LDH release was expressed as
a percentage of the total amount of the enzyme generated through
complete cellular lysis using Triton X-100 (9% [v/v]). The assays
were sensitive enough to detect 0.5 mMN O 2
2 and a concentra-
tion of LDH equivalent to the lysis of 1% of the cell population.
Values (mean6SEM) were calculated over a minimum of six
independent experiments.
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